Phase I study of docetaxel (D) in combination with epirubicin (E) as first line chemotherapy in metastatic breast cancer

被引：0
|
作者：
Borquez, D
Raab, G
Harstrick, A
Wilke, HJ
Achterrath, W
Eiermann, W
Seeber, S
机构：
[1] Rot Kreuz Hosp, Munich, Germany
[2] W German Canc Ctr, Essen, Germany
[3] Rhone Poulenc Rorer, Cologne, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [21] A Phase I Study of Ixabepilone in Combination With Epirubicin in Patients With Metastatic Breast Cancer
    Roche, Henri
    De Benedictis, Elena
    Cottura, Ewa
    Govi, Silvia
    Dalenc, Florence
    Locatelli, Alberta
    Deslandres, Marion
    Zambetti, Milvia
    Gladieff, Laurence
    Messina, Marianne
    Gianni, Luca
    CLINICAL BREAST CANCER, 2012, 12 (03) : 167 - 174
  • [22] Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    Nabholtz, JM
    Mackey, JR
    Smylie, M
    Paterson, A
    Noël, DR
    Al-Tweigeri, T
    Tonkin, K
    North, S
    Azli, N
    Riva, A
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 314 - 321
  • [23] Epirubicin (EPI) and Taxotere (TXT) as first line chemotherapy in advanced breast cancer: A phase I study
    Michelotti, A
    Venturini, M
    Papaldo, P
    Donati, S
    Del Mastro, L
    Garrone, O
    Bergaglio, M
    Lionetto, R
    Guelfi, M
    Sguotti, C
    Cognetti, F
    Rosso, R
    Conte, PF
    ANNALS OF ONCOLOGY, 1998, 9 : 18 - 18
  • [24] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    Ciardiello, F.
    Troiani, T.
    Caputo, F.
    De Laurentiis, M.
    Tortora, G.
    Palmieri, G.
    De Vita, F.
    Diadema, M. R.
    Orditura, M.
    Colantuoni, G.
    Gridelli, C.
    Catalano, G.
    De Placido, S.
    Bianco, A. R.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1604 - 1609
  • [25] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    F Ciardiello
    T Troiani
    F Caputo
    M De Laurentiis
    G Tortora
    G Palmieri
    F De Vita
    M R Diadema
    M Orditura
    G Colantuoni
    C Gridelli
    G Catalano
    S De Placido
    A R Bianco
    British Journal of Cancer, 2006, 94 : 1604 - 1609
  • [26] Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer
    Campone, M
    Fumoleau, P
    Delecroix, V
    Deporte-Fety, R
    Perrocheau, G
    Vernillet, L
    Borg-Olivier, O
    Louboutin, JP
    Bissery, MC
    Riva, A
    Azli, N
    ANNALS OF ONCOLOGY, 2001, 12 (07) : 909 - 918
  • [27] Phase I study of docetaxel and epirubicin in advanced breast cancer
    Panagos, G
    Mavroudis, D
    Potamianou, A
    Malamos, N
    Kourousis, C
    Kakolyris, S
    Souglakos, J
    Sarra, E
    Giannakakis, T
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 21 - 21
  • [28] A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer
    Delord, Jean Pierre
    Dalenc, Florence
    Pinguet, Frederic
    Nguyen, Laurent
    Lochon, Isabelle
    Poublanc, Muriel
    Chatelut, Etienne
    Roche, Henri
    ONCOLOGY, 2007, 72 (5-6) : 322 - 325
  • [29] Dose finding study of high-dose epirubicin (E) and docetaxel (D) as first-line chemotherapy in advanced breast cancer (ABC)
    Pagani, O
    Sessa, C
    Martinelli, G
    Crivellari, D
    Goldhirsch, A
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S7 - S7
  • [30] First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study
    Pectasides, D
    Dimopoulos, MA
    Aravantinos, G
    Kalophonos, HP
    Papacostas, P
    Briasoulis, E
    Cogas, E
    Papadimitriou, C
    Skarlos, D
    Kosmidis, P
    Fountzilas, G
    ANTICANCER RESEARCH, 2001, 21 (05) : 3575 - 3580
12345